David Coman - Jan 7, 2022 Form 4 Insider Report for Science 37 Holdings, Inc. (SNCE)

Role
Chief Executive Officer
Signature
/s/ Christine Pellizzari, Attorney-in-Fact for David Coman
Stock symbol
SNCE
Transactions as of
Jan 7, 2022
Transactions value $
$0
Form type
4
Date filed
1/11/2022, 08:47 PM
Previous filing
Oct 8, 2021
Next filing
Aug 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNCE Stock Option Award $0 +558K $0.00 558K Jan 7, 2022 Common Stock 558K $11.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Option shall vest and become exercisable as to 25% of the shares of Common Stock subject thereto on January 7, 2023, and the remaining underlying shares will vest in equal monthly installments until fully vested on January 7, 2026, subject to the grantee's continued service as a Service Provider through each applicable vesting date.